Parameters | TAC + MTX (n = 34) | TNFi + MTX (n = 80) | P-value |
---|---|---|---|
Age, years | 51.3 ± 9.7 | 50.5 ± 10.9 | 0.8598 |
Females, n (%) | 31 (91.2) | 64 (80.0) | 0.1430 |
Body mass index, kg/m2 | 23.0 ± 2.5 | 23.0 ± 2.8 | 0.9284 |
Disease duration, months | 95.0 ± 50.8 | 90.3 ± 70.0 | 0.2797 |
RF positivity, n (%) | 27 (79.4) | 65 (81.2) | 0.8219 |
ACPA positivity, n (%) | 32 (94.1) | 64 (80) | 0.0594 |
Tender joint count (0–68) | 0.2 ± 0.7 | 0.2 ± 0.4 | 0.2760 |
Swollen joint count (0–66) | 0.1 ± 0.5 | 0.1 ± 0.3 | 0.8964 |
PhGA (VAS, mm) | 9.3 ± 10.6 | 10.0 ± 8.3 | 0.7022 |
PGA (VAS, mm) | 15.4 ± 14.3 | 17.3 ± 17.9 | 0.5827 |
ESR, mm/h | 21.3 ± 14.9 | 20.6 ± 13.5 | 0.8092 |
CRP, mg/dL | 0.31 ± 0.48 | 0.23 ± 0.30 | 0.2833 |
DAS28-CRP | 1.28 ± 0.48 | 1.25 ± 0.29 | 0.6820 |
HAQ-DI | 0.28 ± 0.32 | 0.43 ± 0.50 | 0.1097 |
Larsen score | 12.5 ± 19.1 | 12.1 ± 20.5 | 0.9190 |
MTX dose, mg/week | 10.0 ± 2.3 | 10.8 ± 2.9 | 0.1398 |
Glucocorticoids, n (%) | 16 (47.1) | 43 (53.8) | 0.5173 |